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Purpose: Depressive and anxiety symptoms are common amongst individuals with
chronic kidney disease and are known to affect quality of life adversely. Psychosocial
interventions have been shown to decrease depressive and anxiety symptoms in
various chronic diseases, but few studies have examined their efficacy in people with
chronic kidney disease and no meta-analysis has been published. Thus, the aim of the
present systematic review and meta-analysis was to evaluate the effects of psychosocial
interventions on depressive and anxiety symptoms as well as quality of life in individuals
diagnosed with chronic kidney disease and/or their carers.
Methods: In this systematic review and meta-analysis, we included published
randomized controlled trials comparing psychosocial interventions versus usual care for
impacting depressive and anxiety symptoms and quality of life.
Results: Eight studies were included in the systematic review and six of these were
subjected to meta-analysis. Psychosocial interventions were associated with a medium
effect size for reduction in depressive symptoms and a small effect size for improved
quality of life in the in individuals with chronic-kidney-disease and their carers. Some
evidence suggested a reduction in anxiety.
Conclusion: Psychosocial interventions appear to reduce depressive symptoms and
improve quality of life in patients with chronic-kidney-disease and their carers and to
have some beneficial impact on anxiety. However, the small number of identified studies
indicates a need for further research in this field.
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INTRODUCTION
Chronic kidney disease (CKD) is a progressive loss in kidney
function characterized by the kidneys failure to clean toxins and
waste products from the blood. The worldwide prevalence of
CKD is 8–16% (Ene-Iordache et al., 2016). There are five stages of
CKD, measured using a test of glomerular-filtration-rate (GFR),
which estimates how much blood passes through the glomeruli
each minute. A GFR of <15 ml/min is referred to as stage-
5 of CKD, marking kidney failure and the need for dialysis; it
is also termed end-stage-kidney-disease (ESKD) (Kidney Health
Australia, 2016b). Approximately 500,000 individuals worldwide
develop ESKD every year (Ojo, 2014). Accordingly, CKD is a
global challenge (GBD Mortality Causes of Death Collaborators,
2015). The total cost associated with the treatment of CKD in
Australia was AUD$4.1 billion in 2012 (Kidney Health Australia,
2016a), US$55 billion in the USA in 2010 (Honeycutt et al., 2013)
and $1.45 billion in the UK in 2009–2010 (Kerr et al., 2012).
Given the high prevalence and associated cost to the community,
it is important to understand the factors that influence prognosis
in order to achieve the best possible health outcomes.
Depressive and anxiety symptoms are important factors
affecting prognostic outcome and quality of life (QoL) in
individuals with CKD, including ESKD (Lee et al., 2013). Indeed,
renal dialysis places a considerable burden on patients with CKD
and often compromises their QoL, leading to high levels of
anxiety and depression (Theofilou, 2011). Self-reports show that
depressive symptoms and anxiety affect∼25% of individuals with
CKD (Stasiak et al., 2014). Using Structured Clinical Interview,
71% of haemodialysis patients met the criteria for clinical anxiety
according to the Diagnostic and Statistical Manual of Mental
Disorders-IV (DSM-IV), in a sample of 70 individuals (Cukor
et al., 2008). Structured Clinical Interview showed that the
prevalence of a major depressive episode was 21% in a sample of
272 consecutive CKD participants and did not vary significantly
among different CKD stages (Hedayati et al., 2009).
Depressive symptoms are associated with reduced treatment
adherence, impaired functional capacity and higher rates of
hospitalization (Hedayati et al., 2010). There is also an association
with increased rates of withdrawal from dialysis and earlier
mortality (Lacson et al., 2012). Despite this, there has been
only limited research on interventions to prevent or manage
depressive symptoms in CKD populations. There has been
even less research into the association between anxiety and
outcomes in this patient group. Very little rigorous research has
investigated how to prevent or manage these issues effectively,
though one study demonstrated that a nurse practitioner model
of care was associated with improved QoL amongst ESKD
patients receiving dialysis (Stanley et al., 2015).
Some studies have reported that psychosocial interventions,
i.e., a combination of psychological [e.g., cognitive behavioral
therapy (CBT)] and social (e.g., social support) components,
decrease depression and anxiety in patients with coronary heart
disease and depression (Subasinghe et al., 2015) and in stroke
(Eldred and Sykes, 2008). However, there is a paucity of studies
examining the role of psychosocial interventions in patients
with CKD. Thus, with a view to determining whether there is
scope to develop further research in this area, we conducted
a systematic review, and where appropriate a meta-analysis,
of studies examining the effects of psychosocial interventions
on depressive symptoms, anxiety symptoms and QoL among
individuals with CKD.
METHODS
This study was conducted following the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines (Moher et al., 2010). A prospective protocol for the
systematic review was not previously published.
Criteria
Eligible studies were randomized controlled trials (RCTs)
published in English that included: individuals or the carers of
individuals diagnosed with CKD (including ESKD); evaluation
of a psychosocial intervention; and outcomes of symptoms
of depression, anxiety, or QoL. Dissertations which had not
been published as scientific papers, were excluded. As we were
interested in the effects of psychosocial interventions in adults,
studies involving children/adolescents were excluded.
Search Strategy
Searches were undertaken in December-2015 and updated
in May-2016 for title or MeSH words, “kidney-disease,”
or “renal-disease,” or “renal-insufficiency,” or “dialysis,” or
“peritoneal-dialysis,” or “hemodialysis,” or “haemodialysis,”
or “kidney-function,” or “kidney-failure,” and the specific
abstract words, “depression,” or “depressive,” “depressed,” or
“melancholia,” or “dysthymia,” or “mood,” or “anxiety,” or
“anxious,” or “quality-of-life,” or “coping,” or “stress,” and the
specific abstract word, “psych∗,” or “motivational-interviewing,”
or “motivational-behavior,” or “behavior-interviewing,” or
“behavior-change,” or “motivational-behavior,” or “behavior-
interviewing,” or “behavior-change,” or “motivational-change,”
or “non-invasive-change. Articles were obtained by searches
of the electronic databases, PubMed, MEDLINE, CINAHL,
PsycINFO, Scopus and Web-of-Science, SocIndex, and the
Cochrane-Central-Register-of-Controlled-Trials (Blackhall,
2007). Authors of eligible studies were contacted to request
unpublished data, where applicable. In studies that included
some non-CKD patients, only data relating to the patients with
CKD was extracted/included in the analyses.
Study Selection
Sourced studies were imported into Covidence Online Software
(https://www.covidence.org). Two independent reviewers
screened studies for relevance based on titles/abstracts and later
full-texts (MCP, SMM) with disagreements resolved through
discussion or by consulting a third reviewer (CFS).
Data Extraction
Data were extracted using a predesigned form and included
study design, country undertaken, aims, ethical information,
studied outcomes, sample size, participant characteristics, and
intervention characteristics. Means (M), standard deviations
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(SD), and sample sizes (n) were extracted. Study authors were
contacted if published data were incomplete or unclear. Data
were extracted independently by two reviewers (MCP, SMM)
with no disagreements arising.
Risk of Bias in Individual Studies and
Grades of Recommendation, Assessment,
Development, and Evaluation
Methodological quality of the included studies was assessed
independently by two reviewers (MCP, SMM) using the
Cochrane Collaboration’s risk of bias assessment tool (Higgins
and Green, 2011). Due to the nature of the studies reviewed,
blinding of participants and personnel was not assessed as it
is not possible to blind the person delivering or receiving the
intervention or usual care (UC). To best capture the current state
and quality of research in this field, papers were not included
or excluded based on quality assessment, and thus all eligible
articles were included. Grades of Recommendation, Assessment,
Development and Evaluation (GRADE), was assessed using the
GRADE working group recommendations as published in the
Cochrane Handbook (Higgins and Green, 2011). We considered
five factors when assessing the quality of evidence, namely:
(1) risk of bias, (2) heterogeneity, (3) population, intervention,
comparison, outcomes (PICO), (4) precision, and (5) publication
bias (Higgins and Green, 2011).
Summary Measures
For themeta-analysis we report the standardizedmean difference
(SMD), where the mean difference in each study is divided by
the SD to create an index that is comparable across studies
(Borenstein et al., 2009). The SMD was used in place of
mean difference as the studies included in the meta-analysis
used different scales not comparable in raw form (Borenstein
et al., 2009). The Hedges’ G (g), form of the SMD was used.
Where multiple outcomes were used to measure the depressive
symptoms, anxiety symptoms, or QoL outcomes, composite
scores using the mean of the relevant scales were used, as shown
in Table 4. Using this validated method, the mean (M) and
variance of the composite are computed by performing a fixed-
effect meta-analysis on the study subgroups, the variance for
the study is half as large as either subgroup since it is based on
double as much information. This procedure forms a composite
effect size and variance, which is then used in the meta-analysis
(Borenstein et al., 2009).
We report the confidence interval (CI), the range in which
the SMD could fall, the Z-value and p-value for testing the null
hypothesis that the mean difference between groups is 0. The
Q-statistic provides a test of the null hypothesis that all studies
in the analysis share a common effect-size. The I2 statistic shows
what proportion of the observed variance reflects differences in
true effect-sizes rather than sampling-error. T2 is the variance of
true effect-sizes or the between study variance. T is the standard
deviation of true-effects (Borenstein et al., 2009).
Data Analysis
Meta-analysis was undertaken using Comprehensive Meta-
Analysis Software Version 3 (CMA Version-3). The primary
analysis compared the effect of intervention groups on depressive
and anxiety symptoms and QoL scores. A funnel plot was
used to investigate any publication bias. Sensitivity analyses
were performed using “one-study-removed” analyses. A random-
effects model was used in all analyses, weighting the studies
based on the sample size/standard error. In cases when pre-
post correlations were not reported in the published papers, we
conducted sensitivity-analysis using a correlation of 0, 0.5, and
0.9, and found the results of our outcomes of interest to be the
same, thus we used a 0 correlation for all analyses.
RESULTS
Study Selection
Search of databases retrieved 2,365 papers with 1,213 duplicates,
leaving 1,152 papers. Title/abstract screening excluded 1,109;
thus, 43 remained for full-text review and ultimately eight
were included (six in the meta-analysis). Initially 11 studies
were identified, but three of these supplied insufficient detail
to determine whether the interventions could be considered
psychosocial or not and thus whether the studies met the
inclusion criteria. The authors of these studies did not respond to
requests for further information so the studies were not included
in the systematic review or meta-analysis (Tsay and Hung, 2004;
Tsay et al., 2005; Lii et al., 2007). Two additional studies did meet
inclusion criteria for the systematic review, but were unable to
provide requisite statistical information to be included in the
meta-analysis: they were still included in the systematic review
(Moattari et al., 2012; Hare et al., 2014). A PRISMA flow-
diagram shows the selection of papers for inclusion and exclusion
(Figure 1).
Study Characteristics
Study specifications are listed in Table 1. One study used a three-
group, parallel-design, comparing a psychosocial intervention
with supportive therapy, or usual care (UC) (Rodrigue et al.,
2011).We extracted data only from the psychosocial intervention
and UC groups. Two studies (Sharp et al., 2005; Hare et al., 2014)
employed a deferred entry method and therefore only outcomes
where the authors maintained a RCT design (before the wait-list
group was assigned to the treatment group) were included in the
meta-analysis. All included studies reported outcomes as pre and
post means and SD within each group.
Sample sizes ranged from 15 to 90 and mean age ranged from
52 to 82 years. Two studies did not report mean participant
age (Cukor et al., 2014; Chan et al., 2015). For one study,
this information was provided by the author upon request
(Chan et al., 2015). The percentage of women ranged from
0 to 79%. In all but three studies (Rodrigue et al., 2011;
Chan et al., 2015) participants were undergoing haemodialysis
and thus were in stage-5 of CKD, or ESKD, and were
recruited from dialysis treatment centers or hospitals. In one
study participants were undergoing peritoneal-dialysis (Hare
et al., 2014). In another study, participants were waiting for
kidney transplantation; 23% were not undergoing dialysis, 58%
were undergoing haemodialysis, and 19% were undergoing
peritoneal-dialysis (Rodrigue et al., 2011). In the third study,
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FIGURE 1 | Flow Chart Showing the Retrieval Process of Trails included in the
Meta-analysis.
participants had selected not to undergo dialysis or enlist for
kidney transplantation (Chan et al., 2015). The psychosocial
interventions in each study varied in their components,
frequency and length as reported in Table 2 (template for
intervention description and replication [TIDiER] table).
Risk of Bias within Studies and Grades of
Recommendation, Assessment,
Development, and Evaluation
All authors were contacted to request any additional unpublished
data. Two authors responded to confirm that they had no
unpublished data (Sharp et al., 2005; Chan et al., 2015). As can
be seen in Table 3, on each of the domains the vast majority of
the included RCTs were rated as having a low or unclear risk
of bias, which is insufficient to justify downgrading the level of
evidence. However, as seen in the meta-analysis results (below),
heterogeneity exists between study outcomes for depressive and
anxiety symptoms. This heterogeneity appears to result from
differences in measurement tools and populations studied. In
terms of PICOs, we consider the population, interventions,
comparison, and outcomes to be sufficiently direct to address
the question at hand. In terms of precision, we consider the
sample sizes to be sufficiently large for the depressive symptoms
and QoL outcomes, and the CI’s on these outcomes to be
sufficiently narrow. For anxiety symptoms, the total sample was
only n = 197. Finally, in terms of publication bias, funnel plots
did not appear to be asymmetric for depressive symptoms or
QoL outcomes. There were too few studies of anxiety symptoms
to assess funnel plots for this outcome reliably. Given the above
considerations, we suggest that the GRADE of evidence should
be downgraded to moderate from high for depressive symptoms
outcomes and from high too low for anxiety symptoms
outcomes.
Limitations in Generalizability and in
Information Reported in Included Studies
The authors did not use a clinical cut-off score of depressive and
anxiety symptoms as an inclusion criterion in five studies that
measured depressive or anxiety symptoms as an outcome (Sharp
et al., 2005; Rodrigue et al., 2011; Chan et al., 2015). Neither did
these authors report the percentage of participants with a clinical
level of depressive and anxiety symptoms at baseline. In one
study, it was not stated whether informed consent was obtained
from participants (Sharp et al., 2005). Implications for policy
were not addressed in four studies (Sharp et al., 2005; Duarte
et al., 2009; Song et al., 2009; Cukor et al., 2014; Chan et al., 2015).
One study was underpowered (Chan et al., 2015) and another
study included only patients of African American ethnicity (Song
et al., 2009). One study had a gender imbalance in the carer study
group (76% female; Chan et al., 2015) another had a primarily
male sample (Hare et al., 2014). One study had non-significant
differences in groups’ baseline Beck Depression Inventory scores
(Duarte et al., 2009).
Meta-Analysis
Table 4 presents a list of studies and tools used to examine
depressive symptoms, anxiety symptoms and QoL, at post
intervention and at 3 months post intervention completion.
Table 4 shows when a composite mean has been used and from
which tools this mean is has been derived, as indicated in
parenthesis.
Depressive Symptoms Outcomes
At post-intervention, five studies measured depressive symptoms
(n = 740). Four of these studies measured symptoms in
patients (Sharp et al., 2005; Duarte et al., 2009; Rodrigue et al.,
2011; Cukor et al., 2014) and one in carers (Chan et al.,
2015) (Figure 2). The results indicate a medium effect (g) of
the psychosocial intervention compared to UC [Z = −4.467,
p = <0.001, Q = 7.266 (4 df ), I2 = 44.950%, T2 = 0.031,
T = 0.175]. Removal of any one study did not alter the
results significantly. Subgroup analysis showed that in the three
studies using a composite measure of depressive symptoms (see
Table 4), that the SMD was −0.618, CI = −0.864 to −0.372,
p = <0.001. The Q-value was 4.040 (2 df ), indicating that
the effect-size still varied across these studies, likely due to
differences in the measurement tools. Conversely, for the two
studies that used the Hospital Anxiety and Depression Scale
(HADS) the effect-size was not significant (SMD=−0.154, CI =
−0.643 to 0.335, p= 0.538), therefore the heterogeneity between
studies appears to result from using different tools to measure
depressive symptoms. Funnel plot results are included in the
Appendix. These results indicate that psychosocial interventions
offer greater relief of depressive symptoms than usual care in
patients with CKD.
Anxiety Outcomes
The analysis of anxiety symptoms post-intervention included
three studies (Figure 2). One of these studies measured
symptoms in carers (Chan et al., 2015) and two measured
symptoms in patients (Sharp et al., 2005; Rodrigue et al.,
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TABLE 3 | Risk of bias assessment for included studies.
References Random sequence
generation
Allocation
concealment
Blinding of outcome
assessment
Attrition
bias
Selective reporting Other bias
Chan et al., 2015 Low Low Low High Low UC
Cukor et al., 2014 UC UC Low Low UC Low
Hare et al.,
2014*
Low UC High Low UC Low
Moattari et al.,
2012
UC UC Low Low UC Low
Duarte et al., 2009 Low Low Low Low UC UC
Rodriguez Garcia and Rodriguez
Garcia, 2011
UC UC Low Low (ITT) UC Low
Sharp et al., 2005* Low Low High Low (ITT) UC UC
Song et al., 2009 Low Low UC Low UC UC
UC, Unclear; ITT, Intention to treat; Random sequence generation’ “UC” method of randomization not specified; Allocation concealment: “UC” studies did not report if allocation
concealment was maintained; Blinding of outcome assessment: “UC” studies did not report if assessors were blind, in “High” studies assessor were not blind; Attrition bias: in the “High”
study 10/14 in the intervention group and 10/15 in the UC condition passed away before study completion; Selective reporting: “UC” Protocols were not available; other sources of
bias: “UC” gender imbalance in the study groups (Sharp et al., 2005). Baseline differences present between groups (Duarte et al., 2009; Song et al., 2009). In the study by Chan et al.,
(Chan et al., 2015) it was not stated why Mann-Whitney test were used instead of T-tests, assumption testing was not reported (Chan et al., 2015). Underlined studies were not used
in the meta-analysis. *Indicates that the same intervention was used.
TABLE 4 | List of studies and tools used in meta-analysis to examine depression, anxiety, or quality of life.
Depression Anxiety Quality of Life
SCALES USED
Study Sample Post Intervention Post Intervention Post Intervention 3 months follow up from
intervention completion
Chan et al., 2015 Patient MQOL
Carer HADS HADS
Cukor et al., 2014 Patient BDI, HAM-D (Composite score
of these used)
KDQOL-SF
Duarte et al., 2009 Patient BDI, MINI (Composite score of
these used)
KDQOL-SF
Rodriguez Garcia and
Rodriguez Garcia, 2011
Patient HSCL, POMS, mentally
unhealthy days (Composite
score of these used)
HSCL, POMS and mentally
unhealthy days
SF-36 (2 composite scales)
QOLI (Composite score of
these used)
SF-36 (2 composite scales)
QOLI (Composite score of
these used)
Sharp et al., 2005 Patient HADS HADS SF-36 (8 subscales)
Song et al., 2009 Patient S-PRT S-PRT
Carer S-PRT S-PRT
S-PRT, 8-item Self-Perception and Relationship Tool; BDI, Becks Depression Inventory; HAM-D, Hamilton Rating Scale for Depression; HSCL, Hopkins Symptom Checklist-25; KDQOL,
Kidney Disease Quality of Life Short Form; MINI, Major Depression module Mini International Neuropsychiatric Interview; POMS, Profile of Mood States; HADS, The Hospital Anxiety
and Depression Scale; MQOL, The McGill Quality of Life Questionnaire; and QOLI, the Quality of Life Inventory.
2011) (n = 197). The results indicated a medium effect of
the intervention [Z = −2.217, p = 0.027, Q = 4.362 (2 df),
I2 = 54.153%, T2 = 0.108, T = 0.329]. Two studies are largely
responsible for the findings, as confirmed by one study removed
analysis, which showed that absence of either of these studies
resulted in a non-significant difference between intervention and
control groups: (Chan et al., 2015; SMD = −0.485, CI = −0.992
to 0.023, Z=−1.870, p= 0.061; Rodriguez Garcia and Rodriguez
Garcia, 2011; SMD = −0.693, CI = −2.004 to 0.617, Z =
−1.037, p = 0.300). The included studies are heterogeneous as
one measured anxiety in carers, another anxiety in patients and
the third used a combined measure of depressive and anxiety
symptoms in patients. Therefore, the heterogeneity between
studies appears to result from including different population
groups. We performed subgroup analyses comparing outcomes
using the different depressive symptom measurement tools. This
showed that the two studies that used the HADS did not find
a significant effect of psychosocial interventions on anxiety
outcomes, SMD = −0.693, CI = −2.004 to 0.617, Z = −1.037,
p= 0.300,Q= 2.922(1 df ), I2 = 65.778%, T2 = 0.634, T = 0.796.
Quality of Life Outcomes
The analysis of QoL symptoms post-intervention included six
studies (n = 412). Five study measured QoL in patients (Sharp
et al., 2005; Duarte et al., 2009; Rodrigue et al., 2011; Cukor et al.,
2014; Chan et al., 2015). In one study, QoL was measured in
both patients and carers (Song et al., 2009), therefore this study
was entered twice into the analysis. The results indicated a small
effect of the intervention (Z = 3.734, p = <0.001, Q = 3.096(6
df), I2, T2, T = 0). One-study-removed analysis showed that
Frontiers in Psychology | www.frontiersin.org 9 June 2017 | Volume 8 | Article 992
Pascoe et al. Psychosocial Interventions, Depression, and CKD
FIGURE 2 | Forest Plot of Psychosocial Interventions on Depressive and Anxious Symptoms by Study. Study used a combination of measured to measure the
outcome of interest = Combined; Standardized mean difference = SMD.
removal of any one study did not change the overall result. Two
studies assessed QoL at 3-months follow up and thus a separate
meta-analysis was conducted including only these studies (Song
et al., 2009; Rodrigue et al., 2011). Thismeta-analysis indicated no
sustained effect of the intervention at 3 months (SMD = 0.256,
CI = −0.054 to 0.567, Z = 1.618, p = 0.106, Q = 2.330(2 df ),
I2 = 14.170%, T2 = 0.011, T = 0.104).
DISCUSSION
In this review, psychosocial interventions appeared to reduce
depressive symptoms and anxiety and improved QoL outcomes
in patients with CKD and/or their carers, compared to usual
care (UC). For depressive symptoms, the magnitude of the SMD
reflects a medium benefit of the intervention; however the effect-
size varied across studies. Three studies used a combinedmeasure
of depressive symptoms and found a significant effect, while
two used the HADS and found no significant effect, suggesting
heterogeneity resulting from differences in outcome measures.
Thus, we suggest that the level of evidence for psychosocial
interventions compared to usual care on depressive symptoms
should be interpreted as moderate rather than high.
For anxiety, the magnitude of the SMD similarly suggests a
medium benefit of psychosocial interventions; however, this is
based on only three studies and did not withstand sensitivity
analysis. Subgroup analysis indicated heterogeneity across
studies, which again was associated with different assessment
tools, as well as differences in the populations studied. The two
studies involving patients contributed 90% to the finding (Sharp
et al., 2005), leaving the effect of psychosocial interventions on
carers’ anxiety, unresolved. For QoL outcomes, the magnitude of
the SMD suggests a small benefit for the intervention; however,
these same benefits were not seen at 3 months follow-up.
Carers and patients were analyzed together in the current
study, raising the question of whether these groups are
sufficiently comparable to be analyzed together. Removal of the
studies involving carers did not change the overall result of
the meta-analysis, indicating that outcomes were similar across
the two population groups in our study. This is particularly
relevant for the QoL outcome, as one study measured QoL in
both patients and carers (Song et al., 2009) and was entered
twice into the analysis. The outcome of these two populations
is likely correlated, so we conducted a separate meta-analysis
including only studies involving patients, which similarly showed
that psychosocial interventions improved QoL compared to UC.
These findings are consistent with our previous meta-analysis
indicating that psychosocial interventions reduce depressive
symptoms and anxiety in patients with cardiovascular disease
(Ski et al., 2015), though this was—like the present study—
limited by only five studies being identified for inclusion (Ski
et al., 2015). The small number of identified studies is testament
to the need for further research in this field. Few researchers are
currently using psychosocial interventions in the health research
field, perhaps due to a lack of clear definition regarding what
constitutes a psychosocial intervention. For example, in a meta-
analysis of 44 trials involving older healthy adults or adults with
sub-clinical depression, the authors concluded that psychosocial
interventions improved QoL and reduced depressive symptoms
(Forsman et al., 2011a,b). However, a range of interventions
were classed as psychosocial, including exercise and reminiscence
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trials (Forsman et al., 2011a,b). Another meta-analysis of RCTs of
psychosocial interventions compared to UC in family members
and patients with various chronic illnesses and reported that
psychosocial interventions had a small significant positive effect
on depressive symptoms (Martire et al., 2004). However, the
characteristics of the interventions of the included studies were
not well-described and the authors stated that they included
all “nonmedical interventions that are psychologically, socially,
or behaviorally oriented” (Martire et al., 2004). Therefore,
previous meta-analyses have included studies that would not be
deemed psychosocial interventions according to our definition
(Thompson and Ski, 2013).
This prompts a discussion about what constitutes a
psychosocial intervention. As highlighted in the meta-analyses
mentioned earlier (Martire et al., 2004; Thompson and Ski, 2013)
the term “psychosocial” is often used in the literature to describe
an intervention that would more accurately be described as
behavioral, educational, psychological, or social. We suggest that
in order to be considered psychosocial, an intervention must
combine a clearly defined psychological component with a social
component (Thompson and Ski, 2013). Better reporting of the
intervention characteristics would aid in transparency regarding
whether interventions are psychosocial or not. At present, there
is a lack of consistency in how psychosocial interventions are
defined, delivered and tested, and this makes the evaluation of
the efficacy of such interventions complicated (Thompson and
Ski, 2013). Accordingly, we took care to ensure that all of the
primary studies included in the present study complied with
the suggested definition of psychosocial interventions i.e., they
combined psychological and social components.
There are three main limitations to the current meta-analysis.
Firstly, all of the primary studies have small sample sizes.
Secondly, three of the primary studies have no assessment of
depressive symptoms at follow-up, two have no assessment of
anxiety outcome at follow-up and five have no assessment of QoL
outcomes at follow-up. Additionally, two studies were identified
in the literature but could not be included in the meta-analysis.
One of these studies failed to find a beneficial effect of the
psychosocial intervention (Hare et al., 2014), while the other
found a beneficial effect on QoL outcomes (Moattari et al., 2012).
As highlighted in the results, in five studies the authors did not
use a clinical cut-off score of depressive and anxiety symptoms
as an inclusion criterion, but measured depressive or anxiety
symptoms as an outcome. These authors also did not report
the percentage of participants with clinical levels of depression
and/or anxiety at baseline (Sharp et al., 2005; Rodrigue et al.,
2011; Hare et al., 2014; Chan et al., 2015). A reduction in
depressive symptoms and anxiety would be difficult to achieve if
a number participants experienced only a low level of depressive
and anxiety symptoms at baseline. Therefore, it is not surprising
that three studies which did not use a clinical cut-off score of
depressive symptoms and anxiety at baseline (Sharp et al., 2005;
Hare et al., 2014; Chan et al., 2015), failed to find a reduction
in these post-intervention. In future studies, we would suggest
that psychosocial interventions aimed to decrease depressive and
anxiety symptoms be targeted toward those experiencing such
symptoms at baseline, in order to best serve the most relevant
patient populations.
None of the included studies reported data on patient consent
rates and uptake of the intervention. Only three studies reported
patient adherence to the intervention (Sharp et al., 2005; Duarte
et al., 2009; Rodrigue et al., 2011) as reported in Table 1. Given
the time requirements of dialysis treatment on CKD patients
and the extensive contact they have with the medical system,
many patients may be reluctant to participate in a time intensive
psychosocial intervention. This is a particular concern given
that many patients feel tired and weak after dialysis. This is
an important consideration in terms of clinical practice, as not
only should clinical interventions be effective, but they must also
be feasible and acceptable to the patients, in order to achieve
sustainable implementation within clinical settings.
Finally, CKD and dialysis treatment is associated with a
number of symptoms which mirror those of anxiety and
depression (American Psychiatric Association, 2013), such as
sleeping problems, changes in appetite, fatigue, and changes
in cognition (Kidney Health Australia, 2017; NHS, 2017). This
is problematic in terms of self-report measures of depressive
and anxiety symptoms, as these may capture symptoms of the
disease and dialysis treatment, rather than being an indicator of
the experience of depressive and anxiety symptoms. Therefore,
careful consideration should be given to the tools used in
order to accurately measure depressive and anxiety symptoms in
populations with CKD.
Overall, the results of the current meta-analysis indicate
that various psychosocial interventions may reduce depressive
symptoms and improve QoL in the carers of and patients
diagnosed with CKD. Preliminary evidence suggests that there
may be a benefit of psychosocial interventions on anxiety
symptoms, for patients diagnosed with CKD.
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